{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:55:10Z","timestamp":1792716910404,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.1001\/jamadermatol.2020.2327","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T15:32:55Z","timestamp":1594222375000},"page":"1117","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma"],"prefix":"10.1001","volume":"156","author":[{"given":"David M.","family":"Schauder","sequence":"first","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwan","family":"Kim","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv I.","family":"Nijhawan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"drv200003r1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in the Netherlands.","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"issue":"2, pt 1","key":"drv200003r2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.","volume":"40","author":"Jensen","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"drv200003r3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/bjd.2006.154.issue-3","article-title":"A population-based study of skin cancer incidence and prevalence in renal transplant recipients.","volume":"154","author":"Moloney","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"drv200003r4","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2014a Swedish population-based study.","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"issue":"10","key":"drv200003r5","article-title":"Post-transplant malignancy in solid organ transplant recipients in Ireland.","volume":"33","author":"O\u2019Neill","year":"2019","journal-title":"Clin Transplant"},{"issue":"5","key":"drv200003r6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/bjd.v181.5","article-title":"Declining incidence of keratinocyte carcinoma in organ transplant recipients.","volume":"181","author":"Menzies","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"drv200003r7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bjd.2016.174.issue-1","article-title":"Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study.","volume":"174","author":"Krynitz","year":"2016","journal-title":"Br J Dermatol"},{"issue":"5","key":"drv200003r8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/00007890-199603150-00008","article-title":"The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study.","volume":"61","author":"Bouwes Bavinck","year":"1996","journal-title":"Transplantation"},{"issue":"9","key":"drv200003r9","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Increased incidence of melanoma in renal transplantation recipients.","volume":"104","author":"Hollenbeak","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"drv200003r10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/bjd.2006.154.issue-3","article-title":"Melanomas in renal transplant recipients.","volume":"154","author":"Le Mire","year":"2006","journal-title":"Br J Dermatol"},{"issue":"11","key":"drv200003r11","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/jid.2015.312","article-title":"Melanoma risk and survival among organ transplant recipients.","volume":"135","author":"Robbins","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"11","key":"drv200003r12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamadermatol.2017.2291","article-title":"Risk factors for melanoma in renal transplant recipients.","volume":"153","author":"Ascha","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"11","key":"drv200003r13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/tri.13011","article-title":"Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.","volume":"30","author":"Fattouh","year":"2017","journal-title":"Transpl Int"},{"issue":"6","key":"drv200003r15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/TP.0b013e3181ec7228","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients.","volume":"90","author":"Lott","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"drv200003r16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"2","key":"drv200003r17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jaad.2017.08.058","article-title":"Cutaneous squamous cell carcinoma: management of advanced and high-stage tumors.","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"drv200003r18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/CAD.0b013e3282f945aa","article-title":"Capecitabine: an overview of the side effects and their management.","volume":"19","author":"Saif","year":"2008","journal-title":"Anticancer Drugs"},{"issue":"3","key":"drv200003r19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archderm.140.3.367","article-title":"Inflammation of actinic keratoses during capecitabine therapy.","volume":"140","author":"Lewis","year":"2004","journal-title":"Arch Dermatol"},{"issue":"4","key":"drv200003r20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1191\/1078155205jp163cr","article-title":"Actinic keratosis and capecitabine therapy.","volume":"11","author":"Higa","year":"2005","journal-title":"J Oncol Pharm Pract"},{"issue":"5","key":"drv200003r21","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.jaad.2005.11.1100","article-title":"Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.","volume":"55","author":"Peramiquel","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"drv200003r22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5070\/D33S83X36N","article-title":"Capecitabine induced inflammation of actinic keratoses.","volume":"13","author":"Krathen","year":"2007","journal-title":"Dermatol Online J"},{"issue":"2","key":"drv200003r23","first-page":"200","article-title":"Inflammation of actinic keratoses with capecitabine therapy for colon cancer.","volume":"18","author":"Serr\u00e3o","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"1","key":"drv200003r24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2230.2011.04114.x","article-title":"Resolving actinic keratoses: an expected side-effect of capecitabine therapy.","volume":"37","author":"Al-Niaimi","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"drv200003r25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/120347541201600504","article-title":"Capecitabine-induced inflammation of actinic keratosis: case report and literature review.","volume":"16","author":"Stanciu","year":"2012","journal-title":"J Cutan Med Surg"},{"issue":"12","key":"drv200003r26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/ijd.13144","article-title":"Multiple inflammatory lesions in an oncology patient.","volume":"55","author":"Pigem","year":"2016","journal-title":"Int J Dermatol"},{"issue":"10","key":"drv200003r27","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1524-4725.2009.01277.x","article-title":"Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine.","volume":"35","author":"Endrizzi","year":"2009","journal-title":"Dermatol Surg"},{"issue":"4","key":"drv200003r28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0012.2010.01348.x","article-title":"Capecitabine for skin cancer prevention in solid organ transplant recipients.","volume":"25","author":"Jirakulaporn","year":"2011","journal-title":"Clin Transplant"},{"issue":"4","key":"drv200003r29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients.","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"issue":"5","key":"drv200003r30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00432-004-0656-6","article-title":"Oral capecitabine plus subcutaneous interferon alpha in advanced squamous cell carcinoma of the skin.","volume":"131","author":"Wollina","year":"2005","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"drv200003r31","first-page":"47","article-title":"Innumerable squamous cell carcinomas in Vietnam War veteran exposed to chemical defoliants.","volume":"12","author":"Desimone","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"drv200003r32","first-page":"807","article-title":"Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.","volume":"40","author":"Konda","year":"2014","journal-title":"Dermatol Surg"},{"issue":"9","key":"drv200003r33","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1111\/ijd.12682","article-title":"Oral capecitabine to prevent recurrent cutaneous squamous cell carcinoma in a lung transplant recipient.","volume":"54","author":"Parikh","year":"2015","journal-title":"Int J Dermatol"},{"issue":"6","key":"drv200003r34","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jdcr.2015.09.009","article-title":"Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients.","volume":"1","author":"Breithaupt","year":"2015","journal-title":"JAAD Case Rep"},{"issue":"2","key":"drv200003r35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaad.2010.11.062","article-title":"Skin cancer in solid organ transplant recipients: advances in therapy and management, part I: epidemiology of skin cancer in solid organ transplant recipients.","volume":"65","author":"O\u2019Reilly Zwald","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"drv200003r36","first-page":"134","article-title":"Safety of chronic low-dose capecitabine as maintenance therapy in gastrointestinal cancers.","volume":"3","author":"Sun","year":"2009","journal-title":"Gastrointest Cancer Res"},{"issue":"1","key":"drv200003r37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00003495-199958010-00006","article-title":"Capecitabine.","volume":"58","author":"Dooley","year":"1999","journal-title":"Drugs"},{"issue":"15","key":"drv200003r38","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2165\/00003495-200161150-00015","article-title":"Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.","volume":"61","author":"McGavin","year":"2001","journal-title":"Drugs"},{"issue":"4","key":"drv200003r39","first-page":"562","article-title":"Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects.","volume":"32","author":"Otley","year":"2006","journal-title":"Dermatol Surg"},{"issue":"1","key":"drv200003r41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression.","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"key":"drv200003r14","unstructured":"Stasko? T, Hanlon? AM. Epidemiology and risk factors for skin cancer in solid organ transplant recipients. UpToDate. Accessed April 9, 2020. https:\/\/www.uptodate.com\/contents\/epidemiology-and-risk-factors-for-skin-cancer-in-solid-organ-transplant-recipients"},{"key":"drv200003r40","unstructured":"Stasko? T, Hanlon? AM. Prevention and management of skin cancer in solid organ transplant recipients. UpToDate. Accessed April 9, 2020. https:\/\/www.uptodate.com\/contents\/prevention-and-management-of-skin-cancer-in-solid-organ-transplant-recipients"},{"key":"drv200003r42","unstructured":"Xeloda (capecitabine). Package insert. Hoffmann-La Roche, Inc: March 2015. Accessed April 19, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020896s037lbl.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2767985\/jamadermatology_schauder_2020_rv_200003_1602515686.26308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T19:21:49Z","timestamp":1667330509000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2767985"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.2327","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}